STOCK TITAN

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference 

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Generation Bio Co. (Nasdaq:GBIO) will present at the 2023 Canaccord Healthcare Conference on August 10, 2023. The presentation will be given by Matt Norkunas, M.D., the company's chief financial officer. The event will take place in Boston at 11:00 a.m. ET and will be live-streamed on the investor section of the company's website. A replay of the presentation will be available for 30 days.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Matt Norkunas, M.D., chief financial officer, will present at the 2023 Canaccord Healthcare Conference on Thursday, August 10, 2023 at 11:00 a.m. ET in Boston.   

A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.  
  
About Generation Bio   
Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or ceDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis, or RES, to produce ceDNA. This approach is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific tissues and cell types, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio’s manufacturing scale to hundreds of millions of doses to support its mission to extend the reach of genetic medicine to more people, living with more diseases, around the world.   

For more information, please visit www.generationbio.com.   
   
Investors and Media Contact  
Maren Killackey  
Generation Bio  
mkillackey@generationbio.com  
857-371-4638  
  

 


FAQ

When and where will Generation Bio Co. present at the 2023 Canaccord Healthcare Conference?

Generation Bio Co. will present at the 2023 Canaccord Healthcare Conference on Thursday, August 10, 2023, at 11:00 a.m. ET in Boston.

Who will be giving the presentation at the conference?

The presentation will be given by Matt Norkunas, M.D., the chief financial officer of Generation Bio Co.

Will the presentation be available online?

Yes, a live webcast of the presentation will be available on the investor section of the company's website at investors.generationbio.com.

Will there be a replay of the presentation?

Yes, a replay of the presentation will be available on the investor section of the company's website for 30 days following the event.

Generation Bio Co.

NASDAQ:GBIO

GBIO Rankings

GBIO Latest News

GBIO Stock Data

155.63M
66.74M
14.52%
84.34%
2.6%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE